The Flavanol (−)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity
- 13 August 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 49 (37), 8127-8133
- https://doi.org/10.1021/bi100939a
Abstract
Islet amyloid polypeptide (IAPP, amylin) is the major protein component of the islet amyloid deposits associated with type 2 diabetes. The polypeptide lacks a well-defined structure in its monomeric state but readily assembles to form amyloid. Amyloid fibrils formed from IAPP, intermediates generated in the assembly of IAPP amyloid, or both are toxic to β-cells, suggesting that islet amyloid formation may contribute to the pathology of type 2 diabetes. There are relatively few reported inhibitors of amyloid formation by IAPP. Here we show that the tea-derived flavanol, (−)-epigallocatechin 3-gallate [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate] (EGCG), is an effective inhibitor of in vitro IAPP amyloid formation and disaggregates preformed amyloid fibrils derived from IAPP. The compound is thus one of a very small set of molecules which have been shown to disaggregate IAPP amyloid fibrils. Fluorescence-detected thioflavin-T binding assays and transmission electron microscopy confirm that the compound inhibits unseeded amyloid fibril formation as well as disaggregates IAPP amyloid. Seeding studies show that the complex formed by IAPP and EGCG does not seed amyloid formation by IAPP. In this regard, the behavior of IAPP is similar to the reported interactions of Aβ and α-synuclein with EGCG. Alamar blue assays and light microscopy indicate that the compound protects cultured rat INS-1 cells against IAPP-induced toxicity. Thus, EGCG offers an interesting lead structure for further development of inhibitors of IAPP amyloid formation and compounds that disaggregate IAPP amyloid.Keywords
This publication has 63 references indexed in Scilit:
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicityProceedings of the National Academy of Sciences, 2010
- Islet amyloid deposition limits the viability of human islet grafts but not porcine islet graftsProceedings of the National Academy of Sciences of the United States of America, 2010
- A synergistic small-molecule combination directly eradicates diverse prion strain structuresNature Chemical Biology, 2009
- A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptidesProtein Engineering, Design and Selection, 2009
- Two-dimensional Infrared Spectroscopy Provides Evidence of an Intermediate in the Membrane-catalyzed Assembly of Diabetic AmyloidThe Journal of Physical Chemistry B, 2009
- Peptide and Protein Mimetics Inhibiting Amyloid β-Peptide AggregationAccounts of Chemical Research, 2008
- Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assemblyProceedings of the National Academy of Sciences, 2008
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomersNature Structural & Molecular Biology, 2008
- Small-molecule aggregates inhibit amyloid polymerizationNature Chemical Biology, 2008
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature, 2004